Exagen Inc. (XGN) Misses Q4 EPS by 1c

Exagen Inc. (NASDAQ: XGN) reported Q4 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $16.63 million versus the consensus estimate of $17.08 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• TechCreate Group faces NYSE American delisting proceedings
• Nvidia pitches Vera CPU to Chinese clients with August delivery target